Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (52)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sato, A.
Right arrow Articles by Suda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, A.
Right arrow Articles by Suda, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 10, 1217-1227, Copyright © 1998 by Oxford University Press


ARTICLES

Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells

A Sato, A Iwama, N Takakura, H Nishio, GD Yancopoulos and T Suda
Department of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, Honjo, Japan.

TEK, or TIE-2, is a receptor tyrosine kinase (RTK) that is known as a functioning molecule of vascular endothelial cells. TEK comprises a subfamily of RTK with TIE, and these two receptors play critical roles in vascular maturation, maintenance of integrity and remodeling. We generated mAb against the extracellular domain of human TEK protein to elucidate its expression pattern in human hematopoietic cells. Flow cytometric analysis of bone marrow cells revealed that TEK was expressed in 27% of CD34+ cells, 20% of c-KIT+ cells and 26% of CD34+CD38- cells, indicating that TEK is expressed in a subset of primitive hematopoietic stem cells (HSC). TEK was also expressed in 20% of CD19+ B lymphocytes but not in other lineage-committed cells. Progenitor assays in methylcellulose culture showed that CD34+TEK+ cells formed significantly less BFU-E and CFU-Mix than CD34+TEK- cells, but there was no difference in the number of CFU-GM between these two populations. Two recently identified TEK ligands, termed Angiopoietin-1 and -2, bound to TEK with similar affinities, and Angiopoietin-1 effectively induced TEK phosphorylation in hematopoietic cells. Angiopoietin-2 also induced a low level of TEK phosphorylation and weakened the phosphorylation induced by Angiopoietin-1, suggestive of an elaborate regulator of the TEK-TEK ligand signaling pathway. Although neither ligands affected the proliferation of TEK-transfected hematopoietic cells or the colony formation of CD34+TEK+ bone marrow cells, both promoted the adhesion of TEK-transfected hematopoietic cells to a collagen matrix or a layer of bone marrow stromal cells. These findings indicate that the TEK-TEK ligand signaling pathway is regulated in a refined manner and is involved in hematopoietic cell- microenvironment interaction.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
V. Y. Lounev, R. Ramachandran, M. N. Wosczyna, M. Yamamoto, A. D.A. Maidment, E. M. Shore, D. L. Glaser, D. J. Goldhamer, and F. S. Kaplan
Identification of Progenitor Cells That Contribute to Heterotopic Skeletogenesis
J. Bone Joint Surg. Am., March 1, 2009; 91(3): 652 - 663.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.-G. Kopp, S. T. Avecilla, A. T. Hooper, S. V. Shmelkov, C. A. Ramos, F. Zhang, and S. Rafii
Tie2 activation contributes to hemangiogenic regeneration after myelosuppression
Blood, July 15, 2005; 106(2): 505 - 513.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Stier, Y. Ko, R. Forkert, C. Lutz, T. Neuhaus, E. Grunewald, T. Cheng, D. Dombkowski, L. M. Calvi, S. R. Rittling, et al.
Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size
J. Exp. Med., June 6, 2005; 201(11): 1781 - 1791.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Tachibana, N. Jones, D. J. Dumont, M. C. Puri, and A. Bernstein
Selective Role of a Distinct Tyrosine Residue on Tie2 in Heart Development and Early Hematopoiesis
Mol. Cell. Biol., June 1, 2005; 25(11): 4693 - 4702.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Audero, I. Cascone, F. Maniero, L. Napione, M. Arese, L. Lanfrancone, and F. Bussolino
Adaptor ShcA Protein Binds Tyrosine Kinase Tie2 Receptor and Regulates Migration and Sprouting but Not Survival of Endothelial Cells
J. Biol. Chem., March 26, 2004; 279(13): 13224 - 13233.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. C. Puri and A. Bernstein
Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis
PNAS, October 28, 2003; 100(22): 12753 - 12758.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. V. Terskikh, T. Miyamoto, C. Chang, L. Diatchenko, and I. L. Weissman
Gene expression analysis of purified hematopoietic stem cells and committed progenitors
Blood, July 1, 2003; 102(1): 94 - 101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. Jones, S. H. Chen, C. Sturk, Z. Master, J. Tran, R. S. Kerbel, and D. J. Dumont
A Unique Autophosphorylation Site on Tie2/Tek Mediates Dok-R Phosphotyrosine Binding Domain Binding and Function
Mol. Cell. Biol., April 15, 2003; 23(8): 2658 - 2668.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. E. Burger, S. Coetzee, W. L. McKeehan, M. Kan, P. Cook, Y. Fan, T. Suda, R. P. Hebbel, N. Novitzky, W. A. Muller, et al.
Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells
Blood, November 15, 2002; 100(10): 3527 - 3535.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Dhanabal, W. J. LaRochelle, M. Jeffers, J. Herrmann, L. Rastelli, W. F. McDonald, R. A. Chillakuru, M. Yang, F. L. Boldog, M. Padigaru, et al.
Angioarrestin: An Antiangiogenic Protein with Tumor-inhibiting Properties
Cancer Res., July 1, 2002; 62(13): 3834 - 3841.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Hewett, S. Nijjar, M. Shams, S. Morgan, J. Gupta, and A. Ahmed
Down-Regulation of Angiopoietin-1 Expression in Menorrhagia
Am. J. Pathol., March 1, 2002; 160(3): 773 - 780.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Y. Mochizuki, T. Nakamura, H. Kanetake, and S. Kanda
Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn
J. Cell Sci., January 1, 2002; 115(1): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Teichert-Kuliszewska, P. C. Maisonpierre, N. Jones, A. I.M. Campbell, Z. Master, M. P. Bendeck, K. Alitalo, D. J. Dumont, G. D. Yancopoulos, and D. J. Stewart
Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2
Cardiovasc Res, February 16, 2001; 49(3): 659 - 670.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-Q. Huang, J.-J. Li, and S. Karpatkin
Identification of a family of alternatively spliced mRNA species of angiopoietin-1
Blood, March 15, 2000; 95(6): 1993 - 1999.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. N. Procopio, P. I. Pelavin, W. M. F. Lee, and N. M. Yeilding
Angiopoietin-1 and -2 Coiled Coil Domains Mediate Distinct Homo-oligomerization Patterns, but Fibrinogen-like Domains Mediate Ligand Activity
J. Biol. Chem., October 15, 1999; 274(42): 30196 - 30201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Lauren, Y. Gunji, and K. Alitalo
Is Angiopoietin-2 Necessary for the Initiation of Tumor Angiogenesis?
Am. J. Pathol., November 1, 1998; 153(5): 1333 - 1339.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.